The Race To Develop A COVID-19 Vaccine: The Finish Line Approaches
A Visual Guide And Q&A On The Frontrunners
Updated: a graphic tracker of key developments from the leading vaccine candidates.
You may also be interested in...
Ahead of anticipated emergency use approvals, Pfizer and Moderna are promoting the benefits of their rival mRNA vaccines.
FDA indicates it expects sponsors and other government agencies to come up with ways to fulfill its request for placebo-controlled studies post-emergency use authorization of COVID-19 vaccines, but neither it nor vaccines advisory committee see a clear way to do this.
Meanwhile, seven former US FDA commissioners issue joint plea for trust in the scientific integrity of the agency.